Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Untamed | B Corp™
start up
United Kingdom
- London
- 08/04/2025
- Series B
- $12,787,396
Most cats aren't eating the diet they should be.
Untamed is the fastest growing subscription-based pet food brand that is redefining how cat owners nourish and care for their pets. We are committed to providing high-quality, nutritious, and ethically sourced food made from all the whole meats our cats need to thrive.
Our mission is to enhance the well-being and happiness of cats whilst raising standards across the industry.
- Industry Pet Services
- Website https://untamed.com/
- LinkedIn https://www.linkedin.com/company/untamedcatfood/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)